Wednesday, September 26, 2018 1:59:51 PM
Approximately 3 years ago, after I sold off all of my NVIV (with a healthy gain), I bought AVXL and, over time, have steadily added to my shares outside of a sell off of some in 2017 that I bought back earlier this year.
I started posting here in 2015- at that time after a bit of DD on the background science (see Hashimoto et al on PubMed searching of "chronic neuroinflammation and sigma 1 receptor" and related articles) - I understood that attacking the primary pathophysiological mechanism to many (if not most) neurodegenerative disorders - the nebulous chronic neuroinflammation - will be the key to solving the mystery of neurodegenerative disorders in general.
While the "amyloid hypothesis" was a good start at solving the mystery - it only seemed to address one aspect of a multifaceted neuroinflammatory process. Clearance of protein aggregates, in essence, can help but only to a small degree initially before the other aspects of chronic neuroinflammation overload the overall complicated feedback loops involved.
2-73, I believe, acts to switch "off" the on/off mechanism that regulates inflammatory cascades. Hence - it seems to have "broad spectrum" potential for numerous, seemingly different, neurological disorders that all share the commonality of being related to a chronic neuroinflammatory pathophysiology.
I have written numerously about my believe in posts past but want to share with you a very interesting poster I came across today - for the science minded found here:
NEUROINFLAMMATION
The poster is divided between the left ("proinflammatory") and right ("antiinflammatory").
LEFT: Aberrant synaptic pruning (? autism related, epilepsy related, genetic disorders related), Demyelination and Axonal Degeneration (MS, dementia(s), ALS, etc), Modulation of BBB Permeability/Immune Cell recruitment (multiple neurological and non-neurological immune related disorders) all occur with inflammation.
RIGHT: Immune-Mediated Aggregate Removal, Cellular Repair and Regeneration - ("restoration of cellular homeostasis") occur once the inflammatory switch is turned off - allowing for body self healing, so to speak.
The past 2 years with silence and minimal information has been frustrating but with the little tidbits we have been getting, nothing has changed from the standpoint that - the scientific basis for 2-73's activity is still yet to be refuted. Now - big presentations lie ahead of us with this CTAD, in my opinion, being THE MAJOR PRESENTATION that we have been waiting for since 2015. This CTAD, in my opinion, will be the herald event that starts the flow away from "amyloid hypothesis" and moves it towards the "restoring of cellular homeostasis". Anavex, in my opinion, will be the first to take the lead.
You may call this hype - I call this studied common sense.
Of course, this is all my own opinion. Biostockclub, sokol, nidan, falconer, ffrol (yes, him) and plenty other posters here all are seemingly on the same page of thought as I am, at present.
Science is slow, changing the course of scientific thought is even slower but when change happens, it will be sudden, it will be quick and it will be all-encompassing.
Perhaps this is why we have been/are being held down for so long. Too much money and vested interest from very wealthy and very influential players in this "game" will lose too much when the change will happen. It WILL be Sudden and unexpected and unlikely to occur exactly on the day of CTAD.
The symphony starts at CTAD but there are 4 movements in this one - the fun starts at the end of the symphony.
Holding on tight!
As usual - this is all in my own opinion.
Recent AVXL News
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
- Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:03:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:31:07 PM
- Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/07/2024 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024 • GlobeNewswire Inc. • 02/01/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 10:01:34 PM
- Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans • GlobeNewswire Inc. • 01/24/2024 12:30:00 PM
- Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 01/16/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:00:34 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM